Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+၀.၂၆%
၁,၀၉၅.၆၃
+၂.၈၉
+၀.၂၆%
—၁,၀၉၂.၇၄၁,၀၉၅.၉၅၁,၁၀၃.၃၂၁,၀၉၄.၇၂——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၆၁%
၆၀၉.၆၃
-၃.၇၃
-၀.၆၁%
—၆၁၃.၃၆၆၁၃.၃၆၆၁၃.၃၆၆၀၉.၅၀——
SIXE
Energy
SIXE
Energy
SIXE
-၀.၁၃%
၁,၁၇၅.၂၇
-၁.၅၂
-၀.၁၃%
—၁,၁၇၆.၇၉၁,၁၇၆.၅၂၁,၁၈၂.၂၅၁,၁၆၆.၆၉——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၄၄%
၁,၇၄၇.၈၉
-၇.၆၅
-၀.၄၄%
—၁,၇၅၅.၅၄၁,၇၅၉.၂၃၁,၇၆၆.၃၀၁,၇၄၆.၉၈——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၆၇%
၆၃၀.၉၂
-၄.၂၃
-၀.၆၇%
—၆၃၅.၁၅၆၃၅.၂၀၆၃၆.၈၉၆၃၀.၇၆——
SIXR
Staples
SIXR
Staples
SIXR
+၀.၄၁%
၈၅၁.၄၇
+၃.၄၆
+၀.၄၁%
—၈၄၈.၀၁၈၅၂.၅၂၈၅၅.၇၈၈၅၀.၁၇——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၀.၃၉%
၂၁၈.၇၀
+၀.၈၄
+၀.၃၉%
—၂၁၇.၈၆၂၁၇.၈၆၂၁၉.၅၂၂၁၇.၈၆——
SIXT
Technology
SIXT
Technology
SIXT
+၂.၉၆%
၃,၅၁၈.၄၈
+၁၀၁.၁၃
+၂.၉၆%
—၃,၄၁၇.၃၅၃,၄၅၂.၇၇၃,၅၃၁.၄၅၃,၄၅၀.၃၉——
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၅၀%
၉၀၈.၇၇
-၄.၅၉
-၀.၅၀%
—၉၁၃.၃၆၉၁၅.၁၀၉၂၀.၄၃၉၀၄.၉၄——
SIXV
Health care
SIXV
Health care
SIXV
-၀.၉၄%
၁,၄၄၈.၆၄
-၁၃.၇၄
-၀.၉၄%
—၁,၄၆၂.၃၈၁,၄၆၁.၁၃၁,၄၆၄.၅၃၁,၄၄၇.၁၉——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၁၁%
၂,၄၂၅.၉၁
+၂.၇၇
+၀.၁၁%
—၂,၄၂၃.၁၄၂,၄၂၈.၇၁၂,၄၄၈.၆၉၂,၄၂၄.၆၃——
Q1 2026 earnings • released • EPS beat +၈.၇၀% • Revenue miss -၇.၀၀%
See results
PACB:NASDAQ
Pacific Biosciences of California Inc
၁.၃၉ US$
-၁၅.၇၆%
(-၀.၂၆) 1D
မေ ၈, GMT-၄ ၁၅:၁၄:၅၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PACB...
Open
၁.၅၂ US$
High
၁.၅၂ US$
Low
၁.၃၅ US$
Mkt. cap
၄၃.၁၆ ကုဋေ
Avg. vol.
၆.၃၃ သန်း
Volume
၇.၇၅ သန်း
52-wk high
၂.၇၃ US$
52-wk low
၀.၈၅ US$
EPS
-၀.၄၃ US$
Beta
၂.၄၀
Shares outstanding
၃၀.၂၀ ကုဋေ
No. of employees
၄၈၅
News stories
From sources across the web
StockStory
StockStory
·
ပြီးခဲ့သည့် ၇ မိနစ်
PACB Q1 Deep Dive: Consumables Growth and Clinical Adoption Offset Instrument Weakness
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
Pacific Biosciences stock (US6932471010): Flat Q1 revenue amid funding pressure in U.S. research sec
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၁ နာရီ
Pacific Biosciences (PACB) Shares Drop Following Q1 Revenue Miss
The Chronicle-Journal
The Chronicle-Journal
·
ပြီးခဲ့သည့် ၂ နာရီ
Why PacBio (PACB) Shares Are Getting Obliterated Today
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees၄၈၅
Founded၂၀၀၄
HeadquartersMenlo Park, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitepacb.com
Last report
၂၀၂၆ မေ ၇
Fiscal Period
Q1 2026
EPS / Est. (USD)
-၀.၁၂ US$ / -၀.၁၃ US$
+၈.၇၀%beat
Revenue / Est. (USD)
၃.၇၂ ကုဋေ / ၄.၀၀ ကုဋေ
-၇.၀၀%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ မတ်
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
Revenue
၃.၇၂ ကုဋေ
၃.၉၈ ကုဋေ
၃.၈၄ ကုဋေ
၄.၄၆ ကုဋေ
Cost of goods sold
၃.၀၁ ကုဋေ
၂.၄၉ ကုဋေ
၂.၂၃ ကုဋေ
၄.၀၃ ကုဋေ
Cost of revenue
၃.၀၁ ကုဋေ
၂.၄၉ ကုဋေ
၂.၂၃ ကုဋေ
၄.၀၃ ကုဋေ
Research and development expenses
၂.၉၁ ကုဋေ
၂.၂၅ ကုဋေ
၂.၂၈ ကုဋေ
၂.၃၅ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၀၂ ကုဋေ
၃.၆၂ ကုဋေ
၃.၁၁ ကုဋေ
၃.၅၈ ကုဋေ
Operating expense
၄၃.၉၇ ကုဋေ
၅.၉၇ ကုဋေ
၅.၅၀ ကုဋေ
၆.၄၄ ကုဋေ
Total operating expenses
၄၆.၉၈ ကုဋေ
၈.၄၆ ကုဋေ
၇.၇၂ ကုဋေ
၁၀.၄၇ ကုဋေ
Operating income
-၄၃.၂၆ ကုဋေ
-၄.၄၈ ကုဋေ
-၃.၈၈ ကုဋေ
-၆.၀၁ ကုဋေ
Other non operating income
၂.၅၉ သန်း
၄.၆၇ သန်း
၂.၉၂ သန်း
၆.၄၈ သန်း
EBT including unusual items
-၄၂.၆၄ ကုဋေ
-၄.၁၉ ကုဋေ
-၃.၇၆ ကုဋေ
-၄.၀၂ ကုဋေ
EBT excluding unusual items
-၄၃.၁၈ ကုဋေ
-၄.၁၉ ကုဋေ
-၃.၇၆ ကုဋေ
-၅.၅၃ ကုဋေ
Income tax expense
-၃.၀၂ သိန်း
၃.၅၀ သောင်း
၃.၈၃ သိန်း
၂.၀၂ သိန်း
Effective tax rate
၀.၀၇%
-၀.၀၈%
-၁.၀၂%
-၀.၅၀%
Other operating expenses
၄.၀၇ သန်း
-
-
၄.၁၈ သန်း
Net income
-၄၂.၆၁ ကုဋေ
-၄.၁၉ ကုဋေ
-၃.၈၀ ကုဋေ
-၄.၀၄ ကုဋေ
Net profit margin
-၁,၁၄၆.၈၁%
-၁၀၅.၄၄%
-၉၈.၈၅%
-၉၀.၄၃%
Earnings per share
-၀.၁၅
-၀.၁၃
-၀.၁၂
-၀.၁၂
Interest and investment income
-
-
-
-
Interest expense
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၁.၇၄ သန်း
Net interest expenses
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၁.၇၄ သန်း
-၁.၇၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၆.၁၁ ကုဋေ
-၄.၁၂ ကုဋေ
-၃.၅၃ ကုဋေ
-၅.၆၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer